Miriam Cnop
Miriam Cnop is an expert in Endocrinology at Erasmus Hospital (Belgium). As of September 2026, ScienceLeadR ranks Miriam Cnop in the top 1% of experts worldwide for Diabetes Mellitus and Glucose Metabolism Disorders. Miriam Cnop has authored 195 publications, the most recent in 2026, and is an investigator in 4 clinical trials, 2 of them ongoing. SLR score: 839 (community average: 125). How the SLR is computed.
LeadR Profile
Endocrinology
Subspecialties: Biochemistry - Genetics - Gastroenterology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2000 - 2026
Number : 195
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Accuracy of an Interstitial Continuous Glucose Management System in Critically Ill Patients: A Prospective Observational Study. PMID 42765166 — diabetes mellitus, research design, bias, blood glucose, blood, critical illness, intensive care units, continuous glucose monitoring | J Diabetes Sci Technol | 2026 | 0 |
| Transcriptomics of type 1 diabetes progression: a validation study in newly diagnosed patients. PMID 42413288 — diabetes mellitus, genes, biomedical research, disease progression, diagnosis, therapeutics, diabetes mellitus, type 1, gene expression | EBioMedicine | 2026 | 0 |
| Epigenetic landscapes in human pancreatic islets reveal distinct drivers for adaptation to age and type 2 diabetes. PMID 42236498 — diabetes mellitus, genes, islets of langerhans, insulin, biological science disciplines, stress, physiological, insulin secretion, diabetes mellitus, type 2 | Nat Commun | 2026 | 0 |
| From pancreas and islet resources to diabetes insights. PMID 42065736 — diabetes mellitus, islets of langerhans, pancreas | Diabetologia | 2026 | 0 |
| The diabetes-associated K + channel TALK-2 controls human beta cell endoplasmic reticulum Ca 2+ handling, which promotes basal insulin release and limits glucose-stimulated insulin secretion. PMID 41739147 — diabetes mellitus, cells, insulin, insulin secretion, endoplasmic reticulum, membranes, diabetes mellitus, type 2 | Diabetologia | 2026 | 0 |
Clinical Studies 4
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A study to investigate efficacy and safety of teplizumab compared with placebo in participants 1 to 25 years of age with Stage 3 Type 1 Diabetes 2024-519494-19-00 — diabetes mellitus, safety, metabolic diseases, nutritional and metabolic diseases, diabetes mellitus, type 1 | Phase 3 | Recruiting | 2025 |
| A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE PRESERVE) NCT07222332 — diabetes mellitus, cells, aged, diabetes mellitus, type 1, child | Phase 3 | Recruiting | 2026 |
LeadR Networks
Main global connection map